Stockscreener 앱 받기
0.7983
2.35%
0.0183
시간 외 거래:
2.59
1.7917
+224.44%
전일 마감가:
$0.78
열려 있는:
$0.7799
하루 거래량:
24,971
Relative Volume:
0.38
시가총액:
$28.89M
수익:
$3.34M
순이익/손실:
$-7.35M
주가수익비율:
-3.3726
EPS:
-0.2367
순현금흐름:
$-4.63M
1주 성능:
+4.43%
1개월 성능:
-0.45%
6개월 성능:
-25.39%
1년 성능:
-44.03%
1일 변동 폭
$0.7544
$0.8108
1주일 범위
$0.7502
$0.85
52주 변동 폭
$0.711
$1.4535
Dyadic International Inc De Stock (DYAI) Company Profile
명칭
Dyadic International Inc De
전화
561-743-8333
주소
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.52 | 3.71B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.58 | 414.42M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
19.91 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.52 | 377.54M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
43.90 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 재개 | H.C. Wainwright | Buy |
| 2025-09-08 | 개시 | Craig Hallum | Buy |
| 2022-07-18 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
Dyadic International Inc De 주식(DYAI)의 최신 뉴스
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - TipRanks
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Alpha-Amylase Market Forecast Points Higher Toward 2035 Amid Sustainable Industrial ShiftNews and Statistics - IndexBox
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - Yahoo Finance
Segmentation, Major Trends, and Competitive Overview of the Industrial Biocatalysts Market - openPR.com
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World
Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World
Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World
iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star
Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com UK
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire
Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com
Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins - Yahoo Finance
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Finviz
Earnings call transcript: Dyadic’s Q3 2025 results miss forecasts, stock dips - Investing.com
Earnings call transcript: Dyadic's Q3 2025 results miss forecasts, stock dips - Investing.com UK
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Dyadic International’s CRISPR Leap: Future Unveiled - timothysykes.com
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - News & Observer
Dyadic (DYAI) and BRIG BIO ink alpha-lactalbumin pact for global nutrition - Stock Titan
DYAIDyadic International Inc., DE Stock Price and Quote - Finviz
Will Dyadic International Inc. stock beat EPS estimatesJuly 2025 Volume & Verified Stock Trade Ideas - moha.gov.vn
Taking on analysts’ expectations and winning: Apyx Medical Corp (APYX) - Setenews
A Look at Greenidge Generation Holdings Inc (GREE) Shares in the Recent Past Indicates Growth - Setenews
Bandera Partners LLC Has $1.37 Million Holdings in Dyadic International Inc. $DYAI - Defense World
AXQ Capital LP Sells 411 Shares of Acuity, Inc. $AYI - Defense World
What momentum shifts mean for Dyadic International Inc.Trade Volume Summary & Weekly Top Gainers Alerts - newser.com
Dyadic International’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Dyadic (DYAI) Q3 2025 Earnings Call Transcript - AOL.com
Dyadic International Inc (DYAI) Q3 2025 Earnings Call Highlights: Transition to Commercial ... By GuruFocus - Investing.com Canada
Dyadic Applied BioSolutions Reports Q3 2025 Earnings and Strategic Shift - TipRanks
Earnings call transcript: Dyadic International Q3 2025 sees revenue miss, stock dips - Investing.com Australia
Dyadic International Inc De (DYAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):